Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to...
Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel digital biomarkers for...